246 - Emerging Issues With Influenza Viruses

Saturday, October 19, 2024

1:45 PM – 3:00 PM US PT

Location: Concourse 152

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Emily Erbelding, MD (she/her/hers)

Director, Division of Microbiology and Infectious Disease NIAID
National Institutes of Health
Rockville, MD, United States
Kanta Subbarao, MBBS, MPH

Director,
WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia
Melbourne, Victoria, Australia

Faculty(s)

RW

Richard Webby, PhD

Member
St. Jude Children's Research Hospital
Memphis, TN, United States
Seema Lakdawala, PhD (she/her/hers)

Associate Professor
Department of Microbiology and Immunology
Emory University
Atlanta, GA, United States
Kanta Subbarao, MBBS, MPH

Director,
WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia
Melbourne, Victoria, Australia

Disclosure(s):

Emily Erbelding, MD: No financial relationships to disclose

Kanta Subbarao, MBBS, MPH: No financial relationships to disclose

Richard Webby, PhD: No financial relationships to disclose

Seema Lakdawala, PhD: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the global threat of h5n1 influenza to human health;
analyze other influenza a viruses that may spillover from animals to humans;
describe the diminishing risk of influenza b (yamagata).

Presentations:

1:45 PM – 2:10 PM US PT

The Public Health Threat of Highly Pathogenic Avian Influenza A(H5N1) Viruses
Speaker: Richard Webby, PhD – St. Jude Children's Research Hospital
2:10 PM – 2:35 PM US PT

Other Emerging Influenza Viruses with Species Crossover Potential
Speaker: Seema Lakdawala, PhD (she/her/hers) – Emory University
2:35 PM – 3:00 PM US PT

What Happened to Influenza B/Yamagata and How Does This Impact Vaccine Composition?
Speaker: Kanta Subbarao, MBBS, MPH – WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Australia